These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3714437)
1. Intra-arterial administration of hexobarbital enantiomers to the rat: disposition and estimation of apparent extraction ratio. Van der Graaff M; Vermeulen NP; Breimer DD Pharm Weekbl Sci; 1986 Apr; 8(2):139-44. PubMed ID: 3714437 [TBL] [Abstract][Full Text] [Related]
2. Disposition of hexobarbital enantiomers in the rat. van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD Drug Metab Dispos; 1983; 11(5):489-93. PubMed ID: 6138236 [TBL] [Abstract][Full Text] [Related]
3. Correlation of apparent intrinsic clearances of simultaneously administered S (+) and d3R (-) hexobarbital in the rat. van der Graaff M; Vermeulen NP; Hofman PH; Breimer DD Biochem Pharmacol; 1987 Apr; 36(8):1321-3. PubMed ID: 3593417 [TBL] [Abstract][Full Text] [Related]
4. Disposition of allylic oxidation pathway metabolites of racemic hexobarbital in the rat. Van der Graaff M; Vermeulen NP; Vinks MH; Breimer DD Eur J Drug Metab Pharmacokinet; 1986; 11(2):107-11. PubMed ID: 3770011 [TBL] [Abstract][Full Text] [Related]
5. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt. van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507 [TBL] [Abstract][Full Text] [Related]
6. Selected ion monitoring analysis of pseudoracemic hexobarbital and its major metabolites in blood and urine of rats. van der Graaff M; Hofman PH; Breimer DD; Vermeulen NP; Knabe J; Schamber L Biomed Mass Spectrom; 1985 Sep; 12(9):464-9. PubMed ID: 2932174 [TBL] [Abstract][Full Text] [Related]
7. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats. van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725 [TBL] [Abstract][Full Text] [Related]
8. Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia. Vermeulen NP; Danhof M; Setiawan I; Breimer DD J Pharmacol Exp Ther; 1983 Jul; 226(1):201-5. PubMed ID: 6864540 [TBL] [Abstract][Full Text] [Related]
9. Correlation between the metabolism of hexobarbital and aminopyrine in vivo in rats. van der Graaff M; Vermeulen NP; Heij P; de Bree H; Breimer DD Xenobiotica; 1986 Dec; 16(12):1091-6. PubMed ID: 3798956 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the enantiomers of hexobarbital studied in the same intact rat and in the same isolated perfused rat liver. Breimer DD; van Rossum JM Eur J Pharmacol; 1974 May; 26(2):321-30. PubMed ID: 4853606 [No Abstract] [Full Text] [Related]
11. Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the rat. Joeres RP; Vermeulen NP; Breimer DD Pharmacology; 1988; 36(3):210-6. PubMed ID: 3368506 [TBL] [Abstract][Full Text] [Related]
12. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study. Groen K; Breimer DD; Jansen EJ; van Bezooijen CF J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964 [TBL] [Abstract][Full Text] [Related]
13. Non-linear pharmacokinetics of sparteine in the rat. Van der Graaff M; Vermeulen NP; Koperdraat MC; Breimer DD Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):181-95. PubMed ID: 3767526 [TBL] [Abstract][Full Text] [Related]
14. Route- and dose-dependent pharmacokinetics of hexobarbitone in the rat: a re-evaluation of the use of sleeping times in metabolic studies. Van der Graaff M; Vermeulen NP; Breimer DD J Pharm Pharmacol; 1985 Aug; 37(8):550-4. PubMed ID: 2864415 [TBL] [Abstract][Full Text] [Related]
15. Enantiospecific quantification of hexobarbital and its metabolites in biological fluids by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Prakash C; Adedoyin A; Wilkinson GR; Blair IA Biol Mass Spectrom; 1991 Sep; 20(9):559-64. PubMed ID: 1782205 [TBL] [Abstract][Full Text] [Related]
16. Influence of age on stereoselective pharmacokinetics and metabolism of hexobarbital in the rat. Vermeulen AM; Belpaire FM; De Smet F; Rosseel MT; Bogaert MG Mech Ageing Dev; 1992 Sep; 65(2-3):167-75. PubMed ID: 1434946 [TBL] [Abstract][Full Text] [Related]
17. Effects of phototherapy on the activity of microsomal mixed-function monooxygenases and the pharmacokinetics of [14C] hexobarbital in jaundiced and heterozygous Gunn rats. Tabata M; Ostrow JD; Webster CC; Zucker GM; Kapitulnik J J Pharmacol Exp Ther; 1986 Mar; 236(3):561-7. PubMed ID: 3950863 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies. van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects. van der Graaff M; Vermeulen NP; Heij P; Boeijinga JK; Breimer DD Biopharm Drug Dispos; 1986; 7(3):265-72. PubMed ID: 3730526 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of pentaerythritol tetranitrate following intra-arterial and oral dosing in the rat. King SY; Fung HL J Pharm Sci; 1986 Mar; 75(3):247-50. PubMed ID: 3701607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]